Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2012

Sep 18, 2012

30016_dirs_2012-09-18_00df46ff-a275-4ba0-abac-35847c1d1180.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2012-09-14

Reporting Person: CRAIG THOMAS (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-09-14 Common Stock M 8000 $17.49 Acquired 18917 Direct
2012-09-14 Common Stock S 8000 $99.29 Disposed 10917 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-09-14 Non-Qualified STock Option (right to buy) $17.49 M 8000 Disposed 2013-05-21 Common Stock (8000) Direct

Footnotes

F1: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $98.95 to $99.52, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.

F2: Grant of options to buy shares of common stock that vest one year from the date of grant 05/21/2003.